Chronic intestinal pseudo-obstruction in the course of systemic sclerosis successfully treated with intravenous immunoglobulins and rituximab
Open Access
- 28 May 2025
- journal article
- Published by Termedia Sp. z.o.o. in Rheumatology
- Vol. 63 (4) , 266-273
Abstract
Chronic intestinal pseudo-obstruction (CIPO) is an infrequent and menacing complication of systemic sclerosis (Ssc). While researchers report positive impact of rituximab (RTX) on CIPO in paraneoplastic syndrome, no case reports exist for SSc-associated CIPO. The aim of this case-based review is to analyses current literature in context of particular CIPO case description. This analysis was based on PubMed/MEDLINE database and was conducted using the selected key terms. Finally 40 studies/case reports and one case description from authors clinical experience were included into comparison and discussion. As conclusion description of successfuly treatment with RTX and intravenous immunoglobulins can confirm the suggestions from other studies that B-cells participate in the pathogenesis of SSc, making RTX a potentially effective therapeutic option also in coexisting CIPO.Keywords
This publication has 38 references indexed in Scilit:
- Therapeutic Monoclonal Antibody Therapies in Chronic Autoimmune Demyelinating NeuropathiesNeurotherapeutics, 2022
- B Cell Depletion Inhibits Fibrosis via Suppression of Profibrotic Macrophage Differentiation in a Mouse Model of Systemic SclerosisArthritis & Rheumatology, 2021
- The Ku complex: recent advances and emerging roles outside of non-homologous end-joiningCellular and Molecular Life Sciences, 2021
- Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature reviewClinical Rheumatology, 2012
- A novel approach to paraneoplastic intestinal pseudo-obstructionSupportive Care in Cancer, 2011
- Long-lasting remission after rituximab treatment in a case of anti-Hu-associated sensory neuronopathy and gastric pseudoobstructionJournal of Neuro-Oncology, 2009
- Paraneoplastic gastro‐intestinal anti‐Hu syndrome in neuroblastomaPediatric Blood & Cancer, 2009
- Gastrointestinal Manifestations of Systemic SclerosisDigestive Diseases and Sciences, 2007
- An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromesJournal of Neurology, 2006
- Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US populationArthritis & Rheumatism, 2003